First Republic Investment Management, Inc. Puma Biotechnology, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 10, 2018	SELL	$59.7 - $99.25 $125,370 - $208,425	-2,100 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$93.85 - $132.45 $197,085 - $278,145	2,100	2,100 $208,000

Others Institutions Holding PBYI

# of Institutions

Shares Held

30.5M

Call Options Held

73.5K

Put Options Held

18.5K

Vanguard Group Inc Valley Forge, PA

3.6M
Shares

$9.29 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$9.22 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.16M
Shares

$8.16 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$7.9 Million
0.59% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$5.03 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $118M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account